FHI Clinical Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • FHI Clinical's estimated annual revenue is currently $47.4M per year.(i)
  • FHI Clinical's estimated revenue per employee is $201,000

Employee Data

  • FHI Clinical has 236 Employees.(i)
  • FHI Clinical grew their employee count by 20% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M250%N/AN/A
#2
$3.2M160%N/AN/A
#3
$73M3639%N/AN/A
#4
$31M15456%N/AN/A
#5
$66.6M2650%$35MN/A
#6
$9.4M4718%N/AN/A
#7
$7.2M36-8%N/AN/A
#8
$165.7M21614%$250.7MN/A
#9
$26.5M132-11%$637.8KN/A
#10
$43.2M215-2%N/AN/A
Add Company

FHI Clinical is a full-service contract research organization (CRO) with the global expertise, responsive approaches and proven solutions to manage complex clinical research in resource-limited settings around the world. With more than 50 staff members across 15 countries and access to FHI 360?s global network of more than 4,000 professionals in more than 60 countries, our team of experts is dedicated to achieving social impact by addressing unmet research needs. We have a proven history of working to address challenges across dozens of therapeutic areas, including infectious diseases (IDs), oncology, neglected tropical diseases (NTDs), emerging and reemerging diseases, and pediatric studies. Visit fhiclinical.com or contact us at info@fhiclinical.com or 919.321.3321 to learn how we can put our diverse clinical and operational expertise to work for you.

keywords:N/A

N/A

Total Funding

236

Number of Employees

$47.4M

Revenue (est)

20%

Employee Growth %

N/A

Valuation

N/A

Accelerator

FHI Clinical News

2022-04-13 - Contract Research Organization Market Statistics, Outlook and ...

To illustrate, in April 2019, FHI 360 had launched a new CRO service called FHI Clinical. This service helps the companies that are part of...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$38.9M244N/AN/A
#2
$73.4M24615%N/A
#3
$38.5M247-3%$25M
#4
$15M25830%N/A
#5
$65.3M2600%N/A